Occam Crest Management LP

Position in PGEN — Precigen, Inc.

CIK 2085909 Darien, CT

Position in PGEN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$20,553,863

+$4,032,636 QoQ

Shares Held

3,605,941

-15.5% QoQ

Ownership

1.01%

of shares outstanding

% of Portfolio

10.24%

of 13F equity value

Holder Rank

#10

of 208 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Occam Crest Management LP holds $59,155,147 across 5 Biotechnology names. PGEN ranks #2 (34.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TGTX	Tg Therapeutics, Inc.	425,000	$23,349,500
2	PGEN	Precigen, Inc. This page	3,605,941	$20,553,863
3	AXSM	Axsome Therapeutics, Inc.	29,800	$7,294,146
4	NVCT	Nuvectis Pharma, Inc.	357,147	$6,567,933
5	IMRX	Immuneering Corp	278,498	$1,389,705

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$20,553,863	3,605,941	-15.5%	Shares	Sole	2026-08-14
2026-03-31	$16,521,227	4,269,051	+21.9%	Shares	Sole	2026-05-15
2025-12-31	$14,637,269	3,501,739	+29.8%	Shares	Sole	2026-02-13
2025-09-30	$8,874,446	2,697,400	—	Shares	Sole	2025-11-14
No filing history on record for this holder in this stock.